{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:19:43Z","timestamp":1791296383713,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,6,8]]},"DOI":"10.1038\/onc.2016.486","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T12:55:53Z","timestamp":1484571353000},"page":"3334-3345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK\/PI3K inhibition or MEK\/CDK4\/6 inhibition"],"prefix":"10.1038","volume":"36","author":[{"given":"H S","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H N","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-W","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-M","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S G","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Y","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Greenbowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T-M","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B C","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"BFonc2016486_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR . The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1664\u20131678.","journal-title":"Cancer"},{"key":"BFonc2016486_CR2","first-page":"739","volume":"5","author":"M Mihajlovic","year":"2012","unstructured":"Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V . Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012; 5: 739\u2013753.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFonc2016486_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1634\/theoncologist.2010-0067","volume":"15","author":"N Seetharamu","year":"2010","unstructured":"Seetharamu N, Ott PA, Pavlick AC . Mucosal melanomas: a case-based review of the literature. Oncologist 2010; 15: 772\u2013781.","journal-title":"Oncologist"},{"key":"BFonc2016486_CR4","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Melanoma. Version 1. 2017. Available at:https:\/\/www.nccn.org\/."},{"key":"BFonc2016486_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R . Melanoma biology and new targeted therapy. Nature 2007; 445: 851\u2013857.","journal-title":"Nature"},{"key":"BFonc2016486_CR6","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/onc.2012.345","volume":"32","author":"RJ Sullivan","year":"2013","unstructured":"Sullivan RJ, Flaherty K . MAP kinase signaling and inhibition in melanoma. Oncogene 2013; 32: 2373\u20132379.","journal-title":"Oncogene"},{"key":"BFonc2016486_CR7","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","volume":"64","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D et al. V599EB-RAF is an oncogene in melanocytes. Cancer Res 2004; 64: 2338\u20132342.","journal-title":"Cancer Res"},{"key":"BFonc2016486_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semcancer.2003.09.015","volume":"14","author":"PM Campbell","year":"2004","unstructured":"Campbell PM, Der CJ . Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 2004; 14: 105\u2013114.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2016486_CR9","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC . Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340\u20134346.","journal-title":"J Clin Oncol"},{"key":"BFonc2016486_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363: 809\u2013819.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711\u2013723.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","volume":"369","author":"O Hamid","year":"2013","unstructured":"Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013; 369: 134\u2013144.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 2015; 372: 30\u201339.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1158\/2159-8290.CD-14-0856","volume":"5","author":"MM Deuker","year":"2015","unstructured":"Deuker MM, Marsh Durban V, Phillips WA, McMahon M . PI3'-kinase inhibition forestalls the onset of MEK1\/2 inhibitor resistance in BRAF-mutated melanoma. Cancer Discov 2015; 5: 143\u2013153.","journal-title":"Cancer Discov"},{"key":"BFonc2016486_CR15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/nm.2941","volume":"18","author":"LN Kwong","year":"2012","unstructured":"Kwong LN, Costello JC, Liu H, Jiang S, Helms TL, Langsdorf AE et al. Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nat Med 2012; 18: 1503\u20131510.","journal-title":"Nat Med"},{"key":"BFonc2016486_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.29825","volume":"138","author":"JS Ross","year":"2016","unstructured":"Ross JS, Wang K, Chmielecki J, Gay L, Johnson A, Chudnovsky J et al. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer 2016; 138: 881\u2013890.","journal-title":"Int J Cancer"},{"key":"BFonc2016486_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.tig.2008.08.007","volume":"24","author":"M McVey","year":"2008","unstructured":"McVey M, Lee SE . MMEJ repair of double-strand breaks (director\u2019s cut): deleted sequences and alternative endings. Trends Genet 2008; 24: 529\u2013538.","journal-title":"Trends Genet"},{"key":"BFonc2016486_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz Jr LA, Kinzler KW . Cancer genome landscapes. Science 2013; 339: 1546\u20131558.","journal-title":"Science"},{"key":"BFonc2016486_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network. Electronic address IMO, Cancer Genome Atlas N. Genomic classification of cutaneous melanoma. Cell 2015; 161: 1681\u20131696.","journal-title":"Cell"},{"key":"BFonc2016486_CR20","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.1073\/pnas.95.16.9214","volume":"95","author":"Jr Cutler RE","year":"1998","unstructured":"Cutler Jr RE, Stephens RM, Saracino MR, Morrison DK . Autoregulation of the Raf-1 serine\/threonine kinase. Proc Natl Acad Sci USA 1998; 95: 9214\u20139219.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016486_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 2012; 367: 107\u2013114.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR22","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507\u20132516.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14982","volume":"526","author":"C Zhang","year":"2015","unstructured":"Zhang C, Spevak W, Zhang Y, Burton EA, Ma Y, Habets G et al. RAF inhibitors that evade paradoxical MAPK pathway activation. Nature 2015; 526: 583\u2013586.","journal-title":"Nature"},{"key":"BFonc2016486_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2014.11.006","volume":"27","author":"MR Girotti","year":"2015","unstructured":"Girotti MR, Lopes F, Preece N, Niculescu-Duvaz D, Zambon A, Davies L et al. Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Cancer Cell 2015; 27: 85\u201396.","journal-title":"Cancer Cell"},{"key":"BFonc2016486_CR25","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1073\/pnas.1216013110","volume":"110","author":"C Posch","year":"2013","unstructured":"Posch C, Moslehi H, Feeney L, Green GA, Ebaee A, Feichtenschlager V et al. Combined targeting of MEK and PI3K\/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanomain vitro and in vivo. Proc Natl Acad Sci USA 2013; 110: 4015\u20134020.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016486_CR26","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-13-1746","volume":"19","author":"KE Hutchinson","year":"2013","unstructured":"Hutchinson KE, Lipson D, Stephens PJ, Otto G, Lehmann BD, Lyle PL et al. BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition. Clin Cancer Res 2013; 19: 6696\u20136702.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016486_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm.2166","volume":"16","author":"N Palanisamy","year":"2010","unstructured":"Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010; 16: 793\u2013798.","journal-title":"Nat Med"},{"key":"BFonc2016486_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/JCI23237","volume":"115","author":"R Ciampi","year":"2005","unstructured":"Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN et al. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 2005; 115: 94\u2013101.","journal-title":"J Clin Invest"},{"key":"BFonc2016486_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/path.2780","volume":"222","author":"JW Jeuken","year":"2010","unstructured":"Jeuken JW, Wesseling P . MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol 2010; 222: 324\u2013328.","journal-title":"J Pathol"},{"key":"BFonc2016486_CR30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/sj.jid.5700725","volume":"127","author":"B Dessars","year":"2007","unstructured":"Dessars B, De Raeve LE, El Housni H, Debouck CJ, Sidon PJ, Morandini R et al. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. J Invest Dermatol 2007; 127: 1468\u20131470.","journal-title":"J Invest Dermatol"},{"key":"BFonc2016486_CR31","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015; 43: D805\u2013D811.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016486_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature08314","volume":"461","author":"T Rajakulendran","year":"2009","unstructured":"Rajakulendran T, Sahmi M, Lefrancois M, Sicheri F, Therrien M . A dimerization-dependent mechanism drives RAF catalytic activation. Nature 2009; 461: 542\u2013545.","journal-title":"Nature"},{"key":"BFonc2016486_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature10662","volume":"480","author":"PI Poulikakos","year":"2011","unstructured":"Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 2011; 480: 387\u2013390.","journal-title":"Nature"},{"key":"BFonc2016486_CR34","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/sj.onc.1207647","volume":"23","author":"J Worm","year":"2004","unstructured":"Worm J, Christensen C, Gronbaek K, Tulchinsky E, Guldberg P . Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 2004; 23: 5215\u20135226.","journal-title":"Oncogene"},{"key":"BFonc2016486_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251\u2013263.","journal-title":"Cell"},{"key":"BFonc2016486_CR36","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.1073\/pnas.1017110108","volume":"108","author":"R Ghai","year":"2011","unstructured":"Ghai R, Mobli M, Norwood SJ, Bugarcic A, Teasdale RD, King GF et al. Phox homology band 4.1\/ezrin\/radixin\/moesin-like proteins function as molecular scaffolds that interact with cargo receptors and Ras GTPases. Proc Natl Acad Sci USA 2011; 108: 7763\u20137768.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016486_CR37","first-page":"193","volume":"386","author":"K Giehl","year":"2005","unstructured":"Giehl K . Oncogenic Ras in tumour progression and metastasis. Biol Chem 2005; 386: 193\u2013205.","journal-title":"Biol Chem"},{"key":"BFonc2016486_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng.1041","volume":"44","author":"MS Stark","year":"2012","unstructured":"Stark MS, Woods SL, Gartside MG, Bonazzi VF, Dutton-Regester K, Aoude LG et al. Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat Genet 2012; 44: 165\u2013169.","journal-title":"Nat Genet"},{"key":"BFonc2016486_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.1026","volume":"44","author":"SI Nikolaev","year":"2012","unstructured":"Nikolaev SI, Rimoldi D, Iseli C, Valsesia A, Robyr D, Gehrig C et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 2012; 44: 133\u2013139.","journal-title":"Nat Genet"},{"key":"BFonc2016486_CR40","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006\u20131014.","journal-title":"Nat Genet"},{"key":"BFonc2016486_CR41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm.3559","volume":"20","author":"EM Van Allen","year":"2014","unstructured":"Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 2014; 20: 682\u2013688.","journal-title":"Nat Med"},{"key":"BFonc2016486_CR42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R . Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26: 589\u2013595.","journal-title":"Bioinformatics"},{"key":"BFonc2016486_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011; 43: 491\u2013498.","journal-title":"Nat Genet"},{"key":"BFonc2016486_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013; 31: 213\u2013219.","journal-title":"Nat Biotechnol"},{"key":"BFonc2016486_CR45","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22: 568\u2013576.","journal-title":"Genome Res"},{"key":"BFonc2016486_CR46","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016486_CR47","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","volume":"369","author":"Y Yang","year":"2013","unstructured":"Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369: 1502\u20131511.","journal-title":"N Engl J Med"},{"key":"BFonc2016486_CR48","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL . TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.","journal-title":"Genome Biol"},{"key":"BFonc2016486_CR49","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28: 511\u2013515.","journal-title":"Nat Biotechnol"},{"key":"BFonc2016486_CR50","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1093\/bioinformatics\/btr467","volume":"27","author":"MK Iyer","year":"2011","unstructured":"Iyer MK, Chinnaiyan AM, Maher CA . ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 2011; 27: 2903\u20132904.","journal-title":"Bioinformatics"},{"key":"BFonc2016486_CR51","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/bioinformatics\/btr310","volume":"27","author":"H Ge","year":"2011","unstructured":"Ge H, Liu K, Juan T, Fang F, Newman M, Hoeck W . FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 2011; 27: 1922\u20131928.","journal-title":"Bioinformatics"},{"key":"BFonc2016486_CR52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC . Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010; 70: 440\u2013446.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2016486","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2016.486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:11:03Z","timestamp":1647879063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":52,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,6,8]]}},"alternative-id":["BFonc2016486"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.486","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]},"assertion":[{"value":"3 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}